Sunday, April 22, 2018
 
 
Company News: Page (1) of 1 - 01/05/18 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
Spruce Biosciences Receives EMA Orphan Drug Designation for SPR001 for the Treatment of Congenital Adrenal Hyperplasia
 
(January 05, 2018)
This article is no longer available,but here are some related topics.


Page: 1


Related Keywords:USA,Medicine,Disease,Pregnancy,Surgery,Pregnancy,Science,Lifestyle,Medical,Adults,
Related Sites: DMN Newswire ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter
 
 
 
 
 
 
 
 
 
 
 
 





Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines